Julia Eve Merkenschlager, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Helper-Inducer | 4 | 2024 | 977 | 1.080 |
Why?
|
| Germinal Center | 3 | 2024 | 380 | 0.970 |
Why?
|
| B-Lymphocytes | 7 | 2024 | 4794 | 0.740 |
Why?
|
| Clone Cells | 3 | 2021 | 1670 | 0.660 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 1439 | 0.470 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 3116 | 0.340 |
Why?
|
| Retroviridae Infections | 3 | 2018 | 148 | 0.310 |
Why?
|
| Antibody Affinity | 2 | 2024 | 253 | 0.260 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11684 | 0.200 |
Why?
|
| Plasma Cells | 1 | 2024 | 599 | 0.190 |
Why?
|
| Lymphocyte Activation | 3 | 2020 | 5505 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2024 | 1393 | 0.170 |
Why?
|
| Leukemia Virus, Murine | 2 | 2018 | 95 | 0.170 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 2414 | 0.170 |
Why?
|
| Leukemia, B-Cell | 1 | 2019 | 86 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2024 | 10486 | 0.150 |
Why?
|
| Friend murine leukemia virus | 1 | 2017 | 37 | 0.150 |
Why?
|
| Antigens | 1 | 2023 | 1444 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 2019 | 4168 | 0.140 |
Why?
|
| Endogenous Retroviruses | 1 | 2018 | 112 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 4413 | 0.140 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 962 | 0.130 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2016 | 72 | 0.130 |
Why?
|
| Leukemia, Experimental | 1 | 2016 | 225 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2016 | 190 | 0.130 |
Why?
|
| AIDS Vaccines | 2 | 2019 | 900 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2024 | 2133 | 0.130 |
Why?
|
| HIV Antibodies | 2 | 2019 | 1341 | 0.130 |
Why?
|
| Macaca mulatta | 2 | 2019 | 2365 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2021 | 2574 | 0.120 |
Why?
|
| Mice | 10 | 2024 | 82072 | 0.120 |
Why?
|
| Cell Separation | 1 | 2019 | 1728 | 0.110 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 824 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 2017 | 641 | 0.110 |
Why?
|
| Tumor Virus Infections | 1 | 2016 | 437 | 0.110 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1252 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 1231 | 0.110 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 1769 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 22379 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2024 | 2748 | 0.100 |
Why?
|
| Animals | 12 | 2024 | 169335 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1803 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 2431 | 0.080 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2016 | 1360 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2019 | 2936 | 0.080 |
Why?
|
| Vaccination | 1 | 2019 | 3438 | 0.070 |
Why?
|
| Cytokines | 1 | 2021 | 7453 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 17173 | 0.060 |
Why?
|
| HIV-1 | 2 | 2019 | 6962 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 10276 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9264 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13674 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 9618 | 0.050 |
Why?
|
| Cell Count | 1 | 2024 | 1833 | 0.040 |
Why?
|
| Cross-Priming | 1 | 2019 | 75 | 0.040 |
Why?
|
| HIV Antigens | 1 | 2019 | 328 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 103 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2019 | 244 | 0.040 |
Why?
|
| Viral Tropism | 1 | 2018 | 102 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2018 | 438 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11932 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 23653 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2017 | 199 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2019 | 513 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2019 | 1065 | 0.030 |
Why?
|
| Male | 6 | 2021 | 365203 | 0.030 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 381 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 13427 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9565 | 0.030 |
Why?
|
| Female | 6 | 2021 | 397515 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2024 | 4625 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 610 | 0.030 |
Why?
|
| Granzymes | 1 | 2016 | 278 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2019 | 649 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 849 | 0.030 |
Why?
|
| Homeostasis | 1 | 2024 | 3347 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 30266 | 0.030 |
Why?
|
| Rabbits | 1 | 2019 | 4774 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3813 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1105 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2019 | 1024 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2683 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 2009 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2016 | 1095 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5404 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 2059 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4290 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 16053 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7609 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14484 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19023 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 30265 | 0.010 |
Why?
|
| HIV Infections | 1 | 2019 | 17591 | 0.010 |
Why?
|
| Humans | 2 | 2019 | 768970 | 0.000 |
Why?
|